Follicle stimulating hormone, commonly abbreviated FSH, is one of the two main hormones the pituitary gland releases to drive reproductive function, and its circulating levels tell a surprisingly detailed story about what is happening inside the ovaries or testes. FSH levels shift dramatically across a person’s lifetime and fluctuate in response to signals from the gonads, so a single number on a lab report can mean very different things depending on age, sex, and context. The hormone does far more than its name suggests, and emerging research points to effects on bone, fat tissue, and even cholesterol that extend well beyond reproduction.
What FSH Actually Does
In women, FSH acts on the granulosa cells that surround developing eggs inside the ovary. It drives those cells to multiply, mature, and switch on the enzymes needed to convert androgens into estrogen. During the early part of each menstrual cycle, a rise in FSH rescues a small group of antral follicles from dying off, pushing them to keep growing until one becomes dominant and is eventually ovulated.1PubMed Central. Granulosa cells and follicular development: a brief review Without that early FSH surge, follicle development stalls and ovulation does not happen.
In men, the FSH receptor sits exclusively on Sertoli cells, the support cells inside the seminiferous tubules of the testes. Sertoli cells create the physical scaffolding and nutritional environment that developing sperm need to survive. FSH signaling establishes a normal number of Sertoli cells during development, promotes their maturation, and later helps maintain the pool of spermatogonia (the stem cells that give rise to sperm). It also keeps germ cells alive by limiting their programmed death.2PubMed Central. Follicle-stimulating hormone signaling in Sertoli cells: a licence to the early stages of spermatogenesis FSH works alongside testosterone to support this process; neither hormone alone is as effective as both together.3PubMed Central. Role of Follicle-Stimulating Hormone in Spermatogenesis
How Your Body Controls FSH Levels
FSH secretion is governed by a feedback loop between the brain and the gonads. The hypothalamus releases gonadotropin-releasing hormone (GnRH) in pulses, and the speed of those pulses matters. Slower pulse frequencies tend to favor FSH release, while faster pulses shift the balance toward luteinizing hormone (LH), the other major pituitary gonadotropin.4Biology of Reproduction. Effects of Gonadotropin-Releasing Hormone Pulse Frequency Modulation on the Reproductive Axis of Photoinhibited Male Siberian Hamsters This frequency-dependent switch helps the body fine-tune the ratio of FSH to LH at different points in the cycle.
The gonads talk back to the pituitary through a protein called inhibin B, which acts as a brake on FSH production. In men, inhibin B is the principal feedback signal keeping FSH in check. As long as Sertoli cells are functioning normally and producing enough inhibin B, FSH stays low. When the seminiferous tubules are damaged and inhibin B drops, FSH climbs.5PubMed Central. Relative roles of inhibin B and sex steroids in the negative feedback regulation of follicle-stimulating hormone in men across the full spectrum of seminiferous epithelium function Sex steroids like testosterone and estrogen also suppress FSH, but their contribution to FSH regulation becomes most apparent only when inhibin B levels are already very low.6European Journal of Endocrinology. Inhibin B in male reproduction: pathophysiology and clinical relevance The system is elegant in its simplicity: when the gonads are healthy, they send enough inhibin and steroid signals to keep FSH dialed down. When gonadal function declines, those braking signals weaken and FSH rises.
How FSH Changes Across Your Lifetime
FSH levels are not static. They follow a distinctive pattern from infancy through old age, and the pattern differs between males and females.
In girls, FSH shows a curious biphasic shape. Levels can be quite high and scattered in infancy, sometimes reaching adult-range values. They then decline through childhood and stay low until puberty begins, at which point FSH climbs again toward adult levels.7Pediatric Research. Pituitary-Gonadal Relations in Female Children and Adolescents In girls, serum FSH rises steadily from about age nine through age thirteen, paralleling the visible stages of pubertal development.8Pediatric Research. Hormonal Changes in Puberty II. Correlation of Serum Luteinizing Hormone and Follicle Stimulating Hormone With Stages of Puberty and Bone Age in Normal Girls
Boys follow a broadly similar trajectory. Prepubertal FSH is low, then rises steadily through the early stages of puberty before leveling off partway through. One study found that serum FSH in prepubertal boys rose from about age nine to age twelve, then continued climbing through age fifteen and beyond.9Pediatric Research. Hormonal Changes in Puberty I. Correlation of Serum Luteinizing Hormone and Follicle Stimulating Hormone with Stages of Puberty, Testicular Size, and Bone Age in Normal Boys In adult men, FSH does not pulse as dramatically as LH does; frequent blood sampling shows that individual men vary widely in their mean FSH, but within a single person the levels do not swing much over the course of a day.
The most dramatic FSH shift happens in women approaching menopause. As the ovarian follicle pool shrinks and the ovaries produce less inhibin and estrogen, the pituitary compensates by cranking out more FSH. This rise begins roughly six years before the final menstrual period and eventually plateaus at a level about fourteen times higher than what is seen in men.10PubMed Central. Follicle-stimulating hormone: More than a marker for menopause: FSH as a frontier for women’s mental health Rising FSH alongside falling estrogen is the hormonal signature of the menopausal transition.11PubMed. The menopause transition: endocrine changes and clinical symptoms
What High FSH Levels Signal
An elevated FSH result on a blood test almost always means the gonads are underperforming. The pituitary is shouting louder because the gonads are not answering. In women, persistently high FSH before age forty, combined with absent periods, points toward premature ovarian failure (sometimes called primary ovarian insufficiency), a condition marked by loss of functional follicles well ahead of the normal menopausal timeline.12PubMed Central. Premature ovarian failure
In men, elevated FSH with normal testosterone and LH typically indicates a problem confined to sperm production. The Sertoli cells are not functioning well enough to make adequate inhibin B, so FSH climbs even though Leydig cell testosterone output remains intact.13PubMed. Redefining abnormal follicle-stimulating hormone in the male infertility population When both FSH and LH are high and testosterone is low, the picture shifts to primary testicular failure, meaning the testes are not producing enough of anything.14The Journal of Clinical Endocrinology & Metabolism. Approach to the Infertile Man Clinicians read these hormone patterns together rather than relying on any single value.
What Low FSH Levels Signal
Abnormally low FSH tells a different story: the problem is upstream, at the level of the hypothalamus or pituitary, rather than in the gonads themselves. In women of reproductive age, the most common cause is functional hypothalamic amenorrhea, which accounts for roughly 30% of secondary amenorrhea cases. It happens when the hypothalamus slows its GnRH pulses in response to stressors like significant weight loss, excessive exercise, or psychological stress, and the pituitary in turn fails to release enough FSH and LH to support ovulation.15PubMed Central. Current understanding of hypothalamic amenorrhoea The encouraging news is that this form of amenorrhea is reversible once the underlying stressor is addressed.16Clinical Obstetrics and Gynecology. What the Generalist Should Know About REI: A Clinician’s Guide to Functional Hypothalamic Amenorrhea
In men, anabolic steroid use is a significant and underappreciated cause of suppressed FSH. Exogenous androgens flood the hypothalamic-pituitary axis with so much steroid signal that GnRH and gonadotropin secretion shut down, leading to reduced sperm production, testicular shrinkage, and subfertility that can persist after cessation.17The Journal of Clinical Endocrinology & Metabolism. Rate and Extent of Recovery from Reproductive and Cardiac Dysfunction Due to Androgen Abuse in Men The suppression of the gonadal axis is a well-documented adverse effect of anabolic-androgenic steroid use in both sexes.18PubMed Central. Diagnosis and Management of Anabolic Androgenic Steroid Use Pituitary tumors, head trauma, and certain genetic conditions can also flatten FSH by damaging the gland directly, though these causes are far less common.
FSH as a Fertility Diagnostic Tool
A blood draw on cycle day three (counting from the first day of menstruation) to measure FSH has been a standard fertility screening step for decades. The logic is straightforward: if the pituitary already has to work hard early in the cycle to recruit follicles, the ovarian reserve is likely diminished. FSH above about 10 IU/L on day three has been linked to fewer retrieved eggs and lower pregnancy rates during IVF, and values above roughly 11.4 mIU/mL show a strong association with failure to conceive through IVF.19PubMed. Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles20Human Reproduction. A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women
There are real limitations, though. A moderately elevated FSH in the 10-to-11 range has poor predictive value on its own, particularly in younger women whose age still works in their favor. Much of its apparent predictive power comes from the fact that women with high FSH also tend to respond poorly to ovarian stimulation drugs, which is itself the more direct obstacle to pregnancy.21Human Reproduction. A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women
Anti-Müllerian hormone (AMH) has increasingly taken over some of FSH’s diagnostic territory. AMH has considerably better sensitivity for detecting diminished ovarian reserve. One study comparing the two markers found AMH had 80% sensitivity versus about 29% for FSH, with nearly identical specificity.22PubMed Central. Comparison of Specificity and Sensitivity of AMH and FSH in Diagnosis of Premature Ovarian Failure AMH also does a better job distinguishing between normal and higher follicle counts, whereas FSH tends only to flag the very low end of the spectrum.23PubMed Central. Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone Interestingly, the relative usefulness of each test shifts with age. In women under 35, day-three FSH correlated more closely with follicle numbers and oocyte retrieval than AMH did. In women 35 and older, AMH was the stronger predictor.24PubMed Central. FSH versus AMH: age-related relevance to ICSI results The practical upshot is that most fertility clinics now use both markers together rather than relying on either alone.
FSH in Fertility Treatment
Injectable FSH is the workhorse drug in IVF and related fertility treatments. When a woman’s own FSH surge is not enough to grow multiple follicles simultaneously (the goal of controlled ovarian stimulation), synthetic or purified FSH is administered by injection to push several follicles to maturity at once. There are two broad categories: recombinant FSH, manufactured in cell culture, and highly purified urinary FSH, derived from the urine of postmenopausal women.
Head-to-head comparisons between these preparations have been running since the late 1990s. A large multinational trial found that recombinant FSH produced more follicles and retrieved more eggs than urinary FSH while requiring fewer injection days.25Human Reproduction. Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH Other studies have found the differences less dramatic, with similar follicle counts and fertilization rates between the two types and only modestly higher pregnancy rates with recombinant FSH that did not reach statistical significance.26PubMed. A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH In practice, clinicians often choose based on cost, availability, and patient preference rather than clear-cut superiority data.
Not all FSH molecules are identical even within the same preparation. FSH comes in different glycosylation variants, meaning the sugar chains attached to the protein differ. These variants appear to have meaningfully different biological effects. Research on pre-antral follicles found that the less heavily glycosylated form (called FSH21/18) promoted rapid follicle growth, while the more glycosylated form (FSH24) failed to increase follicle area at all.27Oxford Academic (Endocrinology). Follicle-Stimulating Hormone Glycosylation Variants Distinctly Modulate Pre-antral Follicle Growth and Survival Some stimulation protocols that sequence different FSH preparations have shown higher pregnancy rates than protocols using recombinant FSH alone, possibly because combining them delivers a mixture of glycoforms closer to what the body naturally produces.28PubMed. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome
Why Some Women Need More FSH Than Others
One of the persistent frustrations in fertility medicine is that two women of the same age, with similar hormone levels, can respond very differently to the same dose of FSH injections. Part of the answer lies in genetics. Variations in the FSH receptor gene influence how sensitively the ovary responds to circulating FSH. A specific variation at position 680 of the receptor gene has been associated with reduced ovarian response when the receptor carries two copies of the serine variant (the Ser/Ser genotype), and these women also tend to have higher baseline FSH levels, as if their pituitary is compensating for a less responsive receptor.29PubMed Central. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs30PubMed. The relationship between FSH receptor polymorphism status and IVF cycle outcome: a retrospective observational study Women carrying the heterozygous Asn/Ser variant, by contrast, tend to produce more follicles and eggs with the same stimulation dose. This kind of genetic variation helps explain why FSH levels alone are an imperfect predictor of how someone will respond to treatment. Two people with the same FSH number may have very different receptor sensitivity.
FSH Beyond Reproduction
For decades, FSH was assumed to target only the gonads. That assumption has been increasingly challenged. Research has shown that FSH receptors exist on osteoclasts, the cells responsible for breaking down bone. When FSH binds these receptors, it stimulates osteoclast activity and promotes bone resorption.31PubMed. FSH versus estrogen: who’s guilty of breaking bones? Laboratory experiments have demonstrated a dose-dependent relationship: increasing concentrations of FSH progressively raise the expression of genes involved in osteoclast function.32PLoS ONE. Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation This raises an intriguing possibility: the rapid bone loss women experience around menopause may not be driven solely by falling estrogen. The simultaneous surge in FSH could be an independent contributor. Animal experiments have even shown that immunizing ovariectomized rats against FSH significantly slowed bone loss and improved bone strength, hinting at an FSH-targeted vaccine strategy for osteoporosis.33PubMed. Immunization with FSHβ fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model
FSH’s extragonadal reach extends further. Epidemiological studies have linked high FSH in menopausal women to changes in body composition, central obesity, and cognitive decline. Laboratory work suggests FSH promotes the growth and proliferation of fat tissue, and blocking the FSH signaling pathway reduces fat accumulation.34PubMed Central. Effects of follicle-stimulating hormone on fat metabolism and cognitive impairment in women during menopause There are even hints about cardiovascular effects: animal experiments have found FSH receptors on liver cells, where FSH appears to activate pathways that ramp up cholesterol production while simultaneously reducing the clearance of LDL cholesterol.35Dove Press (International Journal of Women’s Health). Follicle-Stimulating Hormone and Its Emerging Role in Coronary Atherosclerosis Among Postmenopausal Women: A Comprehensive Review If confirmed in humans, these findings could reshape how we think about the metabolic upheaval women experience during menopause, shifting some of the blame from estrogen deficiency to FSH excess.
The extragonadal research is still young, and most of the stronger evidence comes from animal and cell-culture studies rather than large clinical trials in people. But it represents a genuine shift in how endocrinologists think about FSH. A hormone once considered a narrowly targeted reproductive signal may turn out to be a systemic player in bone health, metabolism, and cardiovascular risk, particularly during the menopausal window when its levels spike highest.